ACIDE TRANEXAMIQUE TILLOMED 0.5 g/5 ml, solution for injection 10 ampoules of 5 ml
Active ingredients: Tranexamic acid
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACIDE TRANEXAMIQUE TILLOMED 0,5 g/5 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- TILLOMED PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Dec 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67420125CIP75509816CIP133400955098164Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE TRANEXAMIQUEsolution | 500 mg · une ampoule de 5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.